Related Experiment Video
Updated: Oct 13, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Canonical and Non-canonical TGFβ Signaling Activate Autophagy in an ULK1-Dependent Manner
Charles B Trelford1, Gianni M Di Guglielmo1
1Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Abstract:
The mechanism(s) in which transforming growth factor beta 1 (TGFβ) modulates autophagy in cancer remain unclear. Here, we characterized the TGFβ signaling pathways that induce autophagy in non-small cell lung cancer cells, using cells lines stably expressing GFP-LC3-RFP-LC3ΔG constructs that measure autophagic flux. We demonstrated that TGFβ1 increases Unc 51-like kinase 1 (ULK1) protein levels, 5' adenosine monophosphate-activated protein kinase (AMPK)-dependent ULK1 phosphorylation at serine (S) 555 and ULK1 complex formation but decreases mechanistic target of rapamycin (mTOR) activity on ULK1. Further analysis revealed that the canonical Smad4 pathway and the non-canonical TGFβ activated kinase 1/tumor necrosis factor receptor-associated factor 6/P38 mitogen activated protein kinase (TAK1-TRAF6-P38 MAPK) pathway are important for TGFβ1-induced autophagy. The TAK1-TRAF6-P38 MAPK pathway was essential for downregulating mTOR S2448 phosphorylation, ULK1 S555 phosphorylation and autophagosome formation. Furthermore, although siRNA-mediated Smad4 silencing did not alter mTOR-dependent ULK1 S757 phosphorylation, it did reduce AMPK-dependent ULK1 S555 phosphorylation and autophagosome formation. Additionally, Smad4 silencing and inhibiting the TAK1-TRAF6-P38 MAPK pathway decreased autophagosome-lysosome co-localization in the presence of TGFβ. Our results suggest that the Smad4 and TAK1-TRAF6-P38 MAPK signaling pathways are essential for TGFβ-induced autophagy and provide specific targets for the inhibition of TGFβ in tumor cells that utilize autophagy in their epithelial-mesenchymal transition program.
Insights
Transforming growth factor beta 1 (TGFβ) activates autophagy in lung cancer cells via Smad4 and TAK1-TRAF6-P38 MAPK pathways. These pathways are crucial for regulating autophagy, offering potential therapeutic targets for cancer treatment.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Signaling
Background:
- The role of transforming growth factor beta 1 (TGFβ) in modulating autophagy within cancer cells is not fully understood.
- Autophagy is a cellular process implicated in cancer progression and treatment resistance.
Purpose of the Study:
- To elucidate the specific TGFβ signaling pathways that induce autophagy in non-small cell lung cancer (NSCLC).
- To identify key molecular players and their interactions in TGFβ-mediated autophagy.
- To explore potential therapeutic targets for inhibiting TGFβ-driven autophagy in cancer.
Main Methods:
- Utilized NSCLC cell lines engineered with GFP-LC3-RFP-LC3ΔG constructs to measure autophagic flux.
- Investigated the impact of TGFβ1 on Unc 51-like kinase 1 (ULK1) phosphorylation and complex formation.
- Employed siRNA-mediated silencing of Smad4 and inhibition of the TAK1-TRAF6-P38 MAPK pathway.
Main Results:
- TGFβ1 increased ULK1 levels, AMPK-dependent ULK1 phosphorylation (S555), and ULK1 complex formation, while decreasing mTOR activity.
- Both the canonical Smad4 pathway and the non-canonical TAK1-TRAF6-P38 MAPK pathway were essential for TGFβ1-induced autophagy.
- The TAK1-TRAF6-P38 MAPK pathway was critical for downregulating mTOR (S2448) and ULK1 (S555) phosphorylation, impacting autophagosome formation.
- Smad4 silencing reduced AMPK-dependent ULK1 phosphorylation (S555) and autophagosome formation.
- Disruption of Smad4 or TAK1-TRAF6-P38 MAPK signaling impaired autophagosome-lysosome co-localization.
Conclusions:
- The Smad4 and TAK1-TRAF6-P38 MAPK signaling pathways are indispensable for TGFβ-induced autophagy in NSCLC.
- These pathways regulate key components of the autophagy machinery, including ULK1 and mTOR.
- Targeting these specific TGFβ signaling pathways could offer a strategy to inhibit autophagy in cancer cells, particularly those undergoing epithelial-mesenchymal transition.
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

